remibrutinib 25 MG Oral Tablet [Rhapsido]

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

remibrutinib 25 MG Oral Tablet [Rhapsido]

25 MG · Oral Tablet · oral

A form of remibrutinib →

remibrutinib 25 MG Oral Tablet [Rhapsido] — Selective immunosuppressants. Strength, form, class, interactions & more.

remibrutinib 25 MG Oral Tablet [Rhapsido]

Active ingredient

Classification

Selective immunosuppressantsKinase Inhibitor

Drug interactions

Remibrutinib has several drug interactions that may affect its exposure and efficacy.

  • majorstrong or moderate CYP3A4 inhibitors — increased risk of adverse reactions
  • majorstrong or moderate CYP3A4 inducers — decreased efficacy of RHAPSIDO
  • moderateP-gp substrates — increased risk of adverse reactions
  • unknownantithrombotic agents — consider risks and benefits of concomitant use

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.